510(k) K892209
K892209 is an FDA 510(k) premarket notification submitted by Intensive Technology, Inc. for the device "APTT BY HEMOCHRON(R)". The FDA issued a decision of Substantially Equivalent on June 22, 1989. The device falls under product code GFO (Activated Partial Thromboplastin), a Class II device regulated under 21 CFR 864.7925. Intensive Technology, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 22, 1989
- Date Received
- April 3, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Activated Partial Thromboplastin
- Device Class
- Class II
- Regulation Number
- 864.7925
- Review Panel
- HE
- Submission Type